The NEOTEC funds have been awarded from the Centre for Technological and Industrial Development (CDTI) and aim to further research to establish a better diagnosis of congenital dyserythropoietic anemia, a rare hereditary disease, and implement a new therapy to cure patients with this disease
The project is directed by Dr Mayka Sánchez, lecturer and researcher at the Department of Basic Sciences, and has the participation of BloodGenetics and CIEMAT (Centre for Energy, Environmental and Technological Research).
The study, entitled “Improvements in the diagnosis and development of molecular tools for gene therapy in congenital dyserythropoietic anaemia”, aims to improve diagnosis and develop molecular gene therapy tools for congenital dyserythropoietic anaemia, a rare, inherited disease that affects the development of red blood cells and is characterized by anaemia and problems in various organs of the body.
To develop this research, the UIC Barcelona
Research Group in Iron Metabolism: Regulation and Disease: will carry out cell cultures with patient samples in the Sant Cugat Campus laboratories, BloodGenetics will develop work to improve genetic diagnosis and discovery of new genes, and CIEMAT will construct and optimise vectors for the development of gene therapy.
